• There is no evidence in the literature for a so-called Candida hypersensitivity syndrome.
• There is no RCT that supports eradication in colonised subjects who do not have an associated disease.
• In certain medical situations, such as in critically ill patients, those undergoing cancer chemotherapy, or those with complication of HIV infection, the majority of studies give evidence for a benefit of prophylactic antifungal therapy, especially in patients who are colonised with yeasts.
• There is limited evidence for any major differences between the possible treatment modalities (for example nystatin, ketoconazole, or fluconazole). In general, side-effects of this treatment are easily managed.
• There is no evidence that long-term treatment is of benefit.
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.